DR. MICHAEL A. HASSMAN, DO

Plain English
This study looked at the effects of a single dose of psilocybin, a compound found in certain mushrooms, on adults with major depressive disorder. Researchers found that those who received psilocybin reported a significant reduction in depression symptoms, with scores dropping by an average of 12.3 points on a depression scale by day 43, compared to those given a placebo. This finding is important because it suggests that psilocybin, when combined with psychological support, could be a new and effective treatment for people suffering from depression. Who this helps: This helps patients with major depressive disorder looking for new treatment options.

Plain English
This study tested the safety and effectiveness of the AZD1222 Covid-19 vaccine in over 32,000 people in the United States, Chile, and Peru. The vaccine showed a significant effectiveness of 74% in preventing symptomatic Covid-19, and for those aged 65 and older, it was even more effective at 83.5%. No severe Covid-19 cases occurred in the vaccinated group compared to eight cases in the placebo group, showing that the vaccine is both safe and effective, especially for older adults. Who this helps: This benefits patients, particularly older adults at higher risk for severe Covid-19.

Plain English
This study looked at how well oseltamivir (a medication) prevents influenza in people living with someone who has the flu. The results showed that oseltamivir was very effective, reducing the risk of the flu by 89% in individuals and 84% in households. This is important because it means that using oseltamivir can help stop the flu from spreading in families and prevent outbreaks. Who this helps: This helps patients and their families by reducing the chances of getting the flu.